Navigation Links
IntelliCell BioSciences Receives US Patent for its Stem Cell Extraction Technology
Date:6/13/2013

living tissue donors for research purposes. IntelliCell is planning a series of in-human clinical studies with top tier universities for the treatment of osteoarthritis, multiple sclerosis, lower limb ischemic wounds, and gum regeneration in the oral cavity as well as medical aesthetics. The Company has developed a first in class cGTP cellular processing facility in New York City, purpose built and designed to be fully integrated into an ambulatory surgery center.

Forward-Looking Statements

Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "will reach," "will change," "will soon," "should," "could," "would," "may," "can" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws. More information about the potential factors that could affect the Company's business and financial results is included in
'/>"/>

SOURCE IntelliCell BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand
2. IntelliCell BioSciences Expands Management Team
3. IntelliCell BioSciences Announces Collaborative Agreement with the University of Florida on Stem Cell and Tissue Repair Research
4. IntelliCell BioSciences Announces Myron Z. Holubiak Joins the IntelliCell BioSciences Board of Directors
5. IntelliCell BioSciences Announces It Will Present and Run Workshop at the 10th Annual Commercialization of Regenerative Medicine in London
6. IntelliCell BioSciences Announces Michael Hershman Joins the IntelliCell BioSciences Board of Directors
7. IntelliCell BioSciences Announces Research Agreement with the New Jersey Center for Biomaterials at Rutgers-The State University of New Jersey
8. IntelliCell BioSciences Announces the Addition of Harry Fisch, MD as Director of Urology
9. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
10. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
11. Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... 21, 2014) The yield so far is small, ... a low-energy, solution-based mineral substitution process to make a ... in electronics and alternative energy devices. , A paper ... the July 21 issue of the journal Inorganic ... in the inorganic and nuclear chemistry fields. The paper ...
(Date:7/21/2014)... ALBANY, New York , July 21, 2014 ... up-to-date research on Global & USA ... Market Size, Trends, and Forecasts ResearchMoz ... USA  Cancer Biomaker Market   to 2018 (Identification, Technologies, ... Strategies, Industry Trends, and Pipeline Analysis. ...
(Date:7/20/2014)... the process releases radioactive krypton and xenon gases. Naturally ... gas radon. A new porous material called CC3 effectively ... Nature Materials shows how: by breathing enough ... , The CC3 material could be helpful in removing ... air in buildings and also in recycling useful elements ...
(Date:7/19/2014)... July 20, 2014 United States ... , GlobalDatas new report, "United States Non-Vascular Stents ... on the United States Non-Vascular Stents market. The ... volume (in units) and average prices (in US ... Biliary Stents and Metal Biliary Stents (Metal Non-Covered ...
Breaking Biology Technology:Oregon chemists eye improved thin films with metal substitution 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 3Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 4Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 5Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 6A noble gas cage 2A noble gas cage 3United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 2United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 3United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 4
... SHANGHAI, China, April 30 /Xinhua-PRNewswire/ -- Today, ... and NovaSecta in,their CRO Service Alliance CROSA ... companies. Tigermed,s expertise in clinical,development complements the ... the alliance., Sundia Meditech, United PharmaTech, ...
... add ... ... TSX symbol: SBS, CALGARY, April 30 /PRNewswire-FirstCall/ - Botaneco, a wholly-owned,subsidiary ... Croda Enterprise Technology, part of Croda,International Plc, an international manufacturer of speciality ingredients,with ...
... For-Profit Healthcare Companies, EL SEGUNDO, Calif., April ... care services, announced it has been honored for,the ... of the Top 125,ranking companies of employee-sponsored workforce ... that demonstrate a deep,commitment to learning and development ...
Cached Biology Technology:Shanghai CRO Service Alliance Adds Clinical Development Capabilities 2Shanghai CRO Service Alliance Adds Clinical Development Capabilities 3Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation 2Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation 3DaVita Honored for 4th Year as Training Top 125 Recipient 2
(Date:7/21/2014)... often results from the strength of immune response, rather ... rather than attacking the virus, might be a better ... the University of Washington, Seattle. She and her collaborators ... that for the H7N9 influenza, and their work has ... this highly virulent strain. The research is published ahead ...
(Date:7/21/2014)... Urban stormwater runoff is causing problems for the ... Environmental Protection Agency found stormwater runoff to be ... environments in rivers, streams, lakes, ponds, reservoirs, bays, ... can harm fish and wildlife populations, foul drinking ... from North Carolina State University are looking to ...
(Date:7/21/2014)... of life are now being developed to try and ... of species. Specifically, a recent model proposed by Petri ... accounts for species interactions with various degrees of symmetry, ... previous, simpler models, which apply random fitness levels to ... demonstrate that the resulting replicator ecosystems do not appear ...
Breaking Biology News(10 mins):Potential new flu drugs target immune response, not virus 2Filter bed substrates, plant types recommended for rain gardens 2Refined biological evolution model 2
... Data publishers should have the option of submitting their ... paper commissioned by the Global Biodiversity Information Facility (GBIF). ... recommendations made by Mark Costello and co-authors in the ... biodiversity data publication , freely available for download ...
... cells from patients with inherited heart muscle disease can ... to patients, including the possibility of testing new treatments ... cell model matches that of the clinical features of ... disease associated with sudden cardiac death Landmark study published ...
... more than 6,000 species of frogs in the world lay ... eggs out of water. This behavior protects the eggs from ... their risk of drying out. Justin Touchon, post-doctoral fellow at ... Panama may be altering frogs, course of evolution. By analyzing ...
Cached Biology News:Peer review option proposed for biodiversity data 2National Heart Centre Singapore develops world's first human heart cell model 2National Heart Centre Singapore develops world's first human heart cell model 3
... raised against a partial recombinant ... PPP4C (NP_002711, 218 a.a. ... protein with GST tag. ... NM_002720 Protein ...
Mouse monoclonal antibody raised against a full length recombinant GPT. NCBI Entrez Gene ID = GPT...
Mouse monoclonal antibody raised against a partial recombinant CAPG. NCBI Entrez Gene ID = CAPG...
Mouse monoclonal antibody raised against a partial recombinant PDE2A. NCBI Entrez Gene ID = PDE2A...
Biology Products: